A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer. Breast Cancer Res Treat. 2025 May; 211(1):111-119.